Učitavanje...
The place of intravenous immunoglobulin in rheumatic diseases
Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2016-01-01
|
| Serija: | Современная ревматология |
| Teme: | |
| Online pristup: | https://mrj.ima-press.net/mrj/article/view/655 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|